JPS57112328A - Hypotensor comprising 2,3-dihydroxypropyl ester of n-(7- chloro-4-quinolyl)anthranillic acid - Google Patents

Hypotensor comprising 2,3-dihydroxypropyl ester of n-(7- chloro-4-quinolyl)anthranillic acid

Info

Publication number
JPS57112328A
JPS57112328A JP18401081A JP18401081A JPS57112328A JP S57112328 A JPS57112328 A JP S57112328A JP 18401081 A JP18401081 A JP 18401081A JP 18401081 A JP18401081 A JP 18401081A JP S57112328 A JPS57112328 A JP S57112328A
Authority
JP
Japan
Prior art keywords
day
hypotensor
quinolyl
chloro
dihydroxypropyl ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP18401081A
Other languages
Japanese (ja)
Other versions
JPS6050767B2 (en
Inventor
Ayanori Takabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP18401081A priority Critical patent/JPS6050767B2/en
Publication of JPS57112328A publication Critical patent/JPS57112328A/en
Publication of JPS6050767B2 publication Critical patent/JPS6050767B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Quinoline Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE: The titled pharmaceutical preparation having low side effect even by long-term medication, comprising 2,3-dihydroxypropyl ester of N-(7-chloro-4-quinolyl)anthranillic acid.
CONSTITUTION: 0.01W10wt%, preferably 1W80wt% compound shown by the formla as an active ingredient is blended with an excipient, bulking agent, binder, wetting agent, etc. to give a hypotensor in the form of powder, granule, tablet, sugar-coated tablet, capsule, suppository, suspension, etc. An oral dose is 1W 200mg/kg/day, preferably 10W100mg/kg/day, and a parenteral dose is 0.05W5mg/ kg/day, preferably 0.2W1mg/kg/day, medicated one W divided four times.
COPYRIGHT: (C)1982,JPO&Japio
JP18401081A 1981-11-17 1981-11-17 Antihypertensive agent containing 2,3-dihydroxypropyl ester of N-(7-chloro-4-quinolyl)anthranilic acid Expired JPS6050767B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP18401081A JPS6050767B2 (en) 1981-11-17 1981-11-17 Antihypertensive agent containing 2,3-dihydroxypropyl ester of N-(7-chloro-4-quinolyl)anthranilic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18401081A JPS6050767B2 (en) 1981-11-17 1981-11-17 Antihypertensive agent containing 2,3-dihydroxypropyl ester of N-(7-chloro-4-quinolyl)anthranilic acid

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP1989280A Division JPS56115718A (en) 1980-02-20 1980-02-20 Physiologically active agent containing 2,3- dihydroxypropyl ester of n- 7-chloro-4-quinolyl anthranylic acid

Publications (2)

Publication Number Publication Date
JPS57112328A true JPS57112328A (en) 1982-07-13
JPS6050767B2 JPS6050767B2 (en) 1985-11-11

Family

ID=16145744

Family Applications (1)

Application Number Title Priority Date Filing Date
JP18401081A Expired JPS6050767B2 (en) 1981-11-17 1981-11-17 Antihypertensive agent containing 2,3-dihydroxypropyl ester of N-(7-chloro-4-quinolyl)anthranilic acid

Country Status (1)

Country Link
JP (1) JPS6050767B2 (en)

Also Published As

Publication number Publication date
JPS6050767B2 (en) 1985-11-11

Similar Documents

Publication Publication Date Title
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
JPS5350316A (en) Drug composition for oral administration
JPS57112328A (en) Hypotensor comprising 2,3-dihydroxypropyl ester of n-(7- chloro-4-quinolyl)anthranillic acid
JPS57112327A (en) Antidiabetic agent comprising 2,3-dihydroxypropyl ester of n-(7-chloro-4-quinolyl)anthranillic acid
JPS57112329A (en) Drug against arterioschlerosis comprising 2,3- dihydroxypropyl ester of n-(7-chloro-4-quinolyl) anthranillic acid
NO164958C (en) PROCEDURE FOR THE PREPARATION OF DIPYRIDAMOL PREPARATIONS WITH PH-INDEPENDENT, REGULATED RELEASE.
JPS57114512A (en) Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivative
JPS55122715A (en) Antidiabetic agent
JPS57158719A (en) Rectal administration pharmaceutical
JPS5612318A (en) Agent for suppressing oxidation of lipid
JPS5675428A (en) Hypoglycemic agent containing procainamide hydrochloride
GB2025224B (en) Pharmaceutical compositions comprising trimethoprim and n ethyl pyridone 3 carboxylic acid derivatives
JPS5536454A (en) Novel immunosuppressive agent
JPS5634626A (en) Anti-inflammatory
JPS5668672A (en) Novel 2-acetoxybenzamide derviative, its preparation, and pharmaceutical containing said derviative as effective component
BE881625A (en) O-ALCOXYCARBONYL-PHENYL ESTERS OF AN ANTHRANILIC ACID, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
JPS57114519A (en) Antiarteriosclerotic agent
JPS57114518A (en) Hypotensive agent
JPS643123A (en) Remedy for skin inflammation
JPS57144216A (en) Antiulcer
JPS5498339A (en) Carcinostatic agent
JPS57114514A (en) Antiphlogistic comprising (3-dimethylcarbamoxyphenyl) trimethyl ammonium derivative
JPS54135231A (en) Cardio-vasocular medicine
JPS5634624A (en) Central nervous system depressant
JPS5675427A (en) Antiarteriosclerotic agent containing procainamide hydrochloride